Dysregulation of Purinergic Signaling Sustains Chronic Inflammation and Oxidative Imbalance in Patients After PitNET Surgical Resection
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26146890 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Geile Fistarol und 17 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Biomedical Science, Federal University of Fronteira Sul, Chapecó 89815-899, SC, Brazil. Hauptthemen laut MEDLINE: Oxidative Stress, Inflammation, Signal Transduction, Pituitary Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina.
Abstract (Originalsprache)
Pituitary neuroendocrine tumors (PitNETs) are the most common intracranial tumors. Evidence suggests that these types of tumors may have high recurrence rates. In this context, the purinergic system, oxidative stress, and inflammation are important signaling pathways involved in the cancer’s pathophysiology. This study aimed to evaluate the sociodemographic and diagnostic profiles, as well as assess the purinergic signaling, immunological, and redox profiles, of patients after PitNET resection. We collected sociodemographic data and the patients’ diagnostic profiles. We also collected blood samples to analyze glycemia, triglycerides, albumin, and ATP levels. The ectonucleotidase activity was determined in peripheral blood mononuclear cells (PBMCs). In addition, we evaluated their redox and immunological profiles. There was a prevalence of gonadotropic macroadenoma derived from PIT-1 cells. We found that patients included in the PitNET group had increased glycemia, serum ATP levels, and ATP hydrolysis in PBMCs. Analyzing their immunological profiles, we found that patients had increased levels of IL-6, IL-10, and TNF, while the IL-27 level was decreased. Regarding their redox profiles, PitNET patients had increased levels of ROS and protein carbonylation. Unexpectedly, patients also showed increased levels of non-protein thiols (NPSHs), total thiols (PSHs), and ascorbic acid. Thus, the dysregulation of purinergic signaling sustained chronic inflammation and oxidative imbalance in PitNET patients for a long time after surgical resection. These data suggest that patients with PitNETs require long-term accompanying to prevent cancer recurrence prognosis. The biomarkers highlighted in this study may be good tools to help the medical approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Biomedical Science, Federal University of Fronteira Sul, Chapecó 89815-899, SC, Brazil.
- Multicentric Postgraduate Program in Biochemistry and Molecular Biology, State University of Santa Catarina, Lages 88520-000, SC, Brazil.
- Postgraduate Program in Biochemistry, University of Santa Catarina, Florianópolis 88040-970, SC, Brazil.
- Department of Nursing, Postgraduate Program in Nursing, Federal University of Santa Catarina, Florianópolis 88040-970, SC, Brazil.
- Center of Health Sciences, Federal University of Santa Maria, Santa Maria 97105-900, RS, Brazil.
- Regional Hospital of West, Center of Neurosurgery, Chapecó 89812-505, SC, Brazil.
ORCID-Profile: Maria L Bergamini, Vitória C de Melo, Micheli M Pillat, Aniela P Kempka, Ariane Zamoner, Margarete D Bagatini
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
- Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
- Federal University of Fronteira Sul (UFFS)
Zitieren
APA
Fistarol, G., de Oliveira, L. A., da Silva, G. B., Manica, D., Hanauer, M. C., Dallagnol, P., Narzetti, R. A., Bergamini, M. L., de Melo, V. C., Vidal, T., Pillat, M. M., de Lima, J., da Cunha, M. L. V., Makiyama, M. L., Marafon, F., Kempka, A. P., Zamoner, A., & Bagatini, M. D. (2025). Dysregulation of Purinergic Signaling Sustains Chronic Inflammation and Oxidative Imbalance in Patients After PitNET Surgical Resection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146890
Vancouver
Fistarol G, de Oliveira LA, da Silva GB, Manica D, Hanauer MC, Dallagnol P, et al. Dysregulation of Purinergic Signaling Sustains Chronic Inflammation and Oxidative Imbalance in Patients After PitNET Surgical Resection. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146890
BibTeX
@article{Fistarol2025,
author = {Fistarol, Geile and de Oliveira, Luiz A and da Silva, Gilnei B and Manica, Daiane and Hanauer, Marceli C and Dallagnol, Paula and Narzetti, Rafael A and Bergamini, Maria L and de Melo, Vitória C and Vidal, Tais and Pillat, Micheli M and de Lima, Jussara and da Cunha, Marcelo L V and Makiyama, Marielle L and Marafon, Filomena and Kempka, Aniela P and Zamoner, Ariane and Bagatini, Margarete D},
title = {Dysregulation of Purinergic Signaling Sustains Chronic Inflammation and Oxidative Imbalance in Patients After PitNET Surgical Resection},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26146890}
}
EUVIMED